Missing Links? Citation Matrix Graphs Glossary  HistCite Guide  About
Tue Aug 31 16:33:17 2004
Naturally secreted oligomers of amyloid beta protein potently
inhibit hippocampal long-term potentiation in vivo

Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R,
Wolfe MS, Rowan MJ, Selkoe DJ
NATURE 416 (6880): 535-539 APR 4 2002
and the citing papers

Nodes: 246
Authors: 958, Journals: 112, Outer References: 9412
Collection span: 2002 - 2004
View: Overview. Sorted by NCR.
Page 1:  1 (698)  2 (58)  3 (30)
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1169825 2002 JOURNAL OF NEUROSCIENCE RESEARCH 70(3):402-437
Teter B; Ashford JW
Neuroplasticity in Alzheimer's disease
03
2150651 2002 PROGRESS IN NEUROBIOLOGY 68(3):209-245
Auld DS; Kornecook TJ; Bastianetto S; Quirion R
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies
119
35402148 2003 NEUROPHARMACOLOGY 45(1):14-44
Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease
110
4530885 2003 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 35(11):1505-1535
Ling Y; Morgan K; Kalsheker N
Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease
35
53290162 2003 PROGRESS IN NEUROBIOLOGY 70(1):1-32
Turner PR; O'Connor K; Tate WP; Abraham WC
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
16
66278190 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(14):1729-1750
Bonifati V; Oostra BA; Heutink P
Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms
00
7124143 2002 NEUROMOLECULAR MEDICINE 2(2):167-196
Chan SL; Furukawa K; Mattson MP
Presenilins and APP in neuritic and synaptic plasticity - Implications for the pathogenesis of Alzheimer's disease
08
81240128 2003 MOLECULAR NEUROBIOLOGY 27(3):249-276
Davis S; Laroche S
What can rodent models tell us about cognitive decline in Alzheimer's disease?
00
92217126 2003 MASS SPECTROMETRY REVIEWS 22(1):1-26
Konermann L; Simmons DA
Protein-folding kinetics and mechanisms studied by pulse-labeling and mass spectrometry
07
103204166 2003 REVIEWS IN THE NEUROSCIENCES 14(4):317-341
Stein TD; Johnson JA
Genetic programming by the proteolytic fragments of the amyloid precursor protein: Somewhere between confusion and clarity
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
111201153 2003 PHARMACOLOGY & THERAPEUTICS 97(1):35-53
Kitamura Y; Nomura Y
Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders
04
1211200109 2003 JOURNAL OF MOLECULAR MEDICINE-JMM 81(11):678-699
Stefani M; Dobson CM
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
515
13619959 2003 ANNUAL REVIEW OF NEUROSCIENCE 26:267-298
Caughey B; Lansbury PT
Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders
731
14118829 2002 MOLECULAR NEUROBIOLOGY 26(2-3):299-316
Echeverria V; Cuello AC
Intracellular A-beta amyloid, a sign for worse things to come?
06
153183230 2004 NATURE REVIEWS NEUROSCIENCE 5(5):347-360
Iadecola C
Neurovascular regulation in the normal brain and in Alzheimer's disease
01
16518263 2003 BEHAVIOURAL PHARMACOLOGY 14(5-6):419-438
Higgins GA; Jacobsen H
Transgenic mouse models of Alzheimer's disease: phenotype and application
02
17717860 2003 ANNUAL REVIEW OF NEUROSCIENCE 26:627-656
Bonini NM; Fortini ME
Human neurodegenerative disease modeling using Drosophila
03
181164156 2003 POLIMERY 48(1):35-43
Jablonowska A; Dadlez M
A beta peptide oligomers - potential neurotoxic agents in Alzheimer's disease
00
1911553 2002 ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS 3:67-99
Selkoe DJ; Podlisny MB
Deciphering the genetic basis of Alzheimer's disease
222
20115423 2002 JOURNAL OF NEUROSCIENCE RESEARCH 69(5):567-577
Kirkitadze MD; Bitan G; Teplow DB
Paradigm shifts in Alzheimer's disease and other neuro degenerative disorders: The emerging role of oligomeric assemblies
1029
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
21115061 2003 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 43:545-584
Selkoe DJ; Schenk D
Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics
729
222148135 2003 NATURE REVIEWS NEUROSCIENCE 4(1):49-60
Soto C
Unfolding the role of protein misfolding in neurodegenerative diseases
342
235145224 2004 JOURNAL OF PEPTIDE SCIENCE 10(5):229-248
Verdier Y; Zarandi M; Penke B
Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: Binding sites and implications for Alzheimer's disease
00
2413139242 2004 PROTEIN AND PEPTIDE LETTERS 11(3):213-228
Walsh DM; Selkoe DJ
Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration
00
25513777 2003 CNS DRUGS 17(9):641-652
Butterfield DA; Pocernich CB
The glutamatergic system and Alzheimer's disease - Therapeutic implications
04
261128228 2004 LANCET 363(9402):51-61
Collins SJ; Lawson VA; Masters CL
Transmissible spongiform encephalopathies
01
276127246 2004 SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY 15(1):17-29
Barral JM; Broadley SA; Schaffar G; Hartl FU
Roles of molecular chaperones in protein misfolding diseases
00
282121140 2003 NEUROCHEMICAL RESEARCH 28(11):1683-1691
Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT
Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies
00
293116191 2004 CURRENT MEDICINAL CHEMISTRY 11(4):491-499
Chow MKM; Lomas DA; Bottomley SP
Promiscuous beta-strand interactions and the conformational diseases
02
303114151 2003 NEW ENGLAND JOURNAL OF MEDICINE 349(6):583-596
Merlini G; Bellotti V
Molecular mechanisms of amyloidosis
120
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
313112209 2004 JOURNAL OF MOLECULAR MEDICINE-JMM 82(3):163-174
Bonifati V; Oostra BA; Heutink P
Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease
13
324106163 2003 PROGRESS IN NEUROBIOLOGY 71(5):385-400
Sousa MM; Saraiva MJ
Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling
00
333103189 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61(3):326-335
Johansson J; Weaver TE; Tjernberg LO
Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid beta-peptide
01
349103245 2004 SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY 15(1):3-16
Dobson CM
Principles of protein folding, misfolding and aggregation
00
3511002 2002 ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 37:31-40
Morgan TE; Krafft GA
Emerging themes in Alzheimer's disease research: Paradigm shift in drug discovery
00
36497176 2004 ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64(1):19-31
Zekanowski C; Religa D; Graff C; Filipek S; Kuznicki J
Genetic aspects of Alzheimer's disease
02
3739638 2002 NATURE REVIEWS DRUG DISCOVERY 1(11):859-866
Wolfe MS
Therapeutic strategies for Alzheimer's disease
126
38195127 2003 MOLECULAR BIOLOGY OF THE CELL 14(11):4541-4556
Ardley HC; Scott GB; Rose SA; Tan NGS; Markham AF; Robinson PA
Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin
19
39195244 2004 REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS 1012:153-163
Huang XD; Moir RD; Tanzi RE; Bush AI; Rogers JT
Redox-active metals, oxidative stress, and Alzheimer's disease pathology
00
40993177 2004 ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64(1):71-79
Koudinov AR; Berezov TT
Alzheimer's amyloid-beta (A beta) is an essential synaptic protein, not neurotoxic junk
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
41292180 2004 ANNALS OF INTERNAL MEDICINE 140(8):627-638
Selkoe DJ
Alzheimer disease: Mechanistic understanding predicts novel therapies
00
4219153 2002 SCIENCE 297(5580):353-356
Hardy J; Selkoe DJ
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
41281
4339178 2003 CURRENT MEDICINAL CHEMISTRY 10(24):2651-2659
Butterfield DA
Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease grain: Mechanisms and consequences
00
44190170 2003 THEORETICAL CHEMISTRY ACCOUNTS 109(1):8-21
Srinivas G; Bagchi B
Study of the dynamics of protein folding through minimalistic models
02
45389169 2003 SWISS MEDICAL WEEKLY 133(19-20):275-282
Johansson J
Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C
02
46988183 2004 BIOCHEMISTRY 43(23):7365-7381
Hurshman AR; White JT; Powers ET; Kelly JW
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization
00
4748781 2003 CURRENT OPINION IN STRUCTURAL BIOLOGY 13(2):146-159
Thirumalai D; Klimov DK; Dima RI
Emerging ideas on the molecular basis of protein and peptide aggregation
213
48586185 2004 BIOPOLYMERS 76(1):4-14
Bateman DA; Chakrabartty A
Interactions of Alzheimer amyloid peptides with cultured cells and brain tissue, and their biological consequences
00
49786216 2004 JOURNAL OF NEUROSCIENCE 24(11):2716-2726
Lin H; Zhai JB; Canete-Soler R; Schlaepfer WW
3 ' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells
00
5018322 2002 JOURNAL OF NEUROCHEMISTRY 83(3):481-489
Bahr BA; Bendiske J
The neuropathogenic contributions of lysosomal dysfunction
120
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
5128347 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99:16412-16418
Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity
420
5228382 2003 CYTOGENETIC AND GENOME RESEARCH 100(1-4):261-275
Kobayashi T; Kakizuka A
Molecular analyses of Machado-Joseph disease
03
5358179 2003 CURRENT OPINION IN GENETICS & DEVELOPMENT 13(3):253-261
Berke SJS; Paulson HL
Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration
318
54481210 2004 JOURNAL OF MOLECULAR NEUROSCIENCE 23(3):235-246
Manelli AM; Stine WB; Van Eldik LJ; Ladu MJ
ApoE and A beta 1-42 interactions
00
5518019 2002 JOURNAL OF CLINICAL INVESTIGATION 110(9):1221-1232
Horwich A
Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions
319
56580227 2004 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 126(7):1992-2005
Hou LM; Shao HY; Zhang YB; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJL; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation
01
57880236 2004 NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 30(3):215-224
Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
Protein misfolding in neurodegenerative diseases
00
5817948 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99:16419-16426
Chiti F; Calamai M; Taddei N; Stefani M; Ramponi G; Dobson CM
Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases
423
5937968 2003 BIOCHEMISTRY 42(36):10863-10873
Cottingham MG; Voskuil JLA; Vaux DJT
The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers
04
60179193 2004 EXPERIMENTAL NEUROLOGY 188(2):224-237
Wen PH; Hof PR; Chen XP; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Sosa MAG; Robakis NK; Haroutunian V; Elder GA
The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
61178138 2003 NEUROCHEMICAL RESEARCH 28(3-4):637-644
Beck M; Bigl V; Rossner S
Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo
01
62178164 2003 PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES 70:163-178
Carrell RW; Huntington JA
How serpins change their fold for better and for worse
01
63178173 2003 TRENDS IN NEUROSCIENCES 26(4):207-214
Bush AI
The metallobiology of Alzheimer's disease
131
641378232 2004 NEUROBIOLOGY OF AGING 25(5):569-580
Klein WL; Stine WB; Teplow DB
Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease
11
6597670 2003 BIOCHEMISTRY 42(44):12749-12760
Chromy BA; Nowak RJ; Lambert MP; Viola KL; Chang L; Velasco PT; Jones BW; Fernandez SJ; Lacor PN; Horowitz P; Finch CE; Krafft GA; Klein WL
Self-assembly of A beta(1-42) into globular neurotoxins
14
6617452 2002 SCIENCE 296(5575):1991-1995
Taylor JP; Hardy J; Fischbeck KH
Biomedicine - Toxic proteins in neurodegenerative disease
9105
6757486 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(13):11612-11622
Stine WB; Dahlgren KN; Krafft GA; LaDu MJ
In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis
716
68274106 2003 JOURNAL OF LIPID RESEARCH 44(8):1423-1430
Raffai RL; Weisgraber KH
Cholesterol: from heart attacks to Alzheimer's disease
04
69373198 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(13):13183-13189
Sirangelo I; Malmo C; Iannuzzi C; Mezzogiorno A; Bianco MR; Papa M; Irace G
Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F
00
7017224 2002 JOURNAL OF NEUROSCIENCE RESEARCH 70(3):298-308
Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: Coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II
01
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
71272235 2004 NEUROBIOLOGY OF DISEASE 16(3):617-629
Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A
Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein
00
7257180 2003 CURRENT OPINION IN RHEUMATOLOGY 15(6):737-744
Askanas V; Engel WK
Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging
02
73871130 2003 NATURE 426(6968):884-890
Dobson CM
Protein folding and misfolding
116
7427087 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(15):13047-13055
Nucifora FC; Ellerby LM; Wellington CL; Wood JD; Herring WJ; Sawa A; Hayden MR; Dawson VL; Dawson TM; Ross CA
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity
05
75570155 2003 PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES 358(1432):821-828
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Synaptic plasticity in animal models of early Alzheimer's disease
14
7616913 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(35):32046-32053
Dahlgren KN; Manelli AM; Stine WB; Baker LK; Krafft GA; LaDu MJ
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability
2437
77369182 2004 ANNALS OF NEUROLOGY 55(6):801-814
Trinchese F; Liu SM; Battaglia F; Walter S; Mathews PM; Arancio O
Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice
00
7826810 2002 HUMAN MOLECULAR GENETICS 11(23):2895-2904
Chan HYE; Warrick JM; Andriola I; Merry D; Bonini NM
Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila
319
79468217 2004 JOURNAL OF NEUROSCIENCE 24(13):3370-3378
Wang QW; Walsh DM; Rowan MJ; Selkoe DJ; Anwyl R
Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5
22
8056794 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(37):34882-34889
Bitan G; Vollers SS; Teplow DB
Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization
25
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
8116676 2003 CHEMISTRY & BIOLOGY 10(2):149-159
Kapurniotu A; Buck A; Weber M; Schmauder A; Hirsch T; Bernhagen J; Tatarek-Nossol M
Conformational restriction via cyclization in beta-amyloid peptide A beta(1-28) leads to an inhibitor of A beta(1-28) amyloidogenesis and cytotoxicity
00
82766122 2003 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 125(50):15359-15365
Bitan G; Tarus B; Vollers SS; Lashuel HA; Condron MM; Straub JE; Teplow DB
A molecular switch in amyloid assembly: Met(35) and amyloid beta-protein oligomerization
24
83266144 2003 NEURON 37(6):925-937
Kamenetz F; Tomita T; Hsieh H; Seabrook G; Borchelt D; Iwatsubo T; Sisodia S; Malinow R
APP processing and synaptic function
931
84366158 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(3):1381-1386
Redwine JM; Kosofsky B; Jacobs RE; Games D; Reilly JF; Morrison JH; Young WG; Bloom FE
Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis
19
8516517 2002 JOURNAL OF BIOLOGICAL CHEMISTRY 277(45):42881-42890
Lashuel HA; Hartley DM; Balakhaneh D; Aggarwal A; Teichberg S; Callaway DJE
New class of inhibitors of amyloid-beta fibril formation - Implications for the mechanism of pathogenesis in Alzheimer's disease
16
8616520 2002 JOURNAL OF CLINICAL INVESTIGATION 110(10):1375-1381
Selkoe DJ
Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease
222
8756588 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(25):23187-23195
Qahwash I; Weiland KL; Lu YF; Sarver RW; Kletzien RF; Yan RQ
Identification of a mutant amyloid peptide that predominantly forms neurotoxic protofibrillar aggregates
11
88265154 2003 PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES 361(1807):1205-1222
Vendruscolo M; Zurdo J; MacPhee CE; Dobson CM
Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems
24
89665203 2004 JOURNAL OF CHEMICAL PHYSICS 120(12):5809-5823
Friedel M; Shea JE
Self-assembly of peptides into a beta-barrel motif
00
901649 2002 FREE RADICAL RESEARCH 36(12):1307-1313
Butterfield DA
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review
232
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
9136483 2003 EMBO JOURNAL 22(3):355-361
Temussi PA; Masino L; Pastore A
From Alzheimer to Huntington: why is a structural understanding so difficult?
116
92563108 2003 JOURNAL OF MOLECULAR BIOLOGY 332(4):795-808
Lashuel HA; Hartley DM; Petre BM; Wall JS; Simon MN; Walz T; Lansbury PT
Mixtures of wild-type and a pathogenic (E22G) form of A beta 40 in vitro accumulate protofibrils, including amyloid pores
48
93263214 2004 JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 63(3):255-261
Takuma H; Tomiyama T; Kuida K; Mori H
Amyloid beta peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo
00
94363222 2004 JOURNAL OF NEUROSCIENCE 24(30):6799-6809
Tong LQ; Balazs R; Thornton PL; Cotman CW
beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons
00
95161105 2003 JOURNAL OF COMPARATIVE NEUROLOGY 462(4):371-381
German DC; Yazdani U; Speciale SG; Pasbakish P; Games D; Liang CL
Cholinergic neuropathology in a mouse model of Alzheimer's disease
04
96161196 2004 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 36(10):2066-2076
Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F
Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell
00
9726072 2003 BIOESSAYS 25(3):283-288
Robinson SR; Bishop GM; Munch G
Alzheimer vaccine: amyloid-beta on trial
25
9826099 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(44):42959-42965
Barnham KJ; Ciccotosto GD; Tickler AK; Ali FE; Smith DG; Williamson NA; Lam YH; Carrington D; Tew D; Kocak G; Volitakis I; Separovic F; Barrow CJ; Wade JD; Masters CL; Cherny RA; Curtain CC; Bush AI; Cappai R
Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation
410
99360141 2003 NEUROCHEMICAL RESEARCH 28(11):1705-1713
Selkoe DJ
Aging, amyloid, and Alzheimer's disease: A perspective in honor of Carl Cotman
00
100459208 2004 JOURNAL OF MOLECULAR BIOLOGY 338(5):943-957
Gliozzi A; Rosano C; Canale C; Bolognesi M; Plakoutsi G; Bucciantini M; Chiti F; Stefani M
Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils
00

Page 1:  1 (698)  2 (58)  3 (30)
Generated by: HistCite(Vlad). Version: 2004.08.24